
On this page, you can update your details, access training courses, and find other helpful resources to support your business membership of Anaphylaxis UK.
Since our rebranding and new website in July 2022, we’ve already reached a staggering number of page views.
Our latest social media campaign reached over 650,000 unique people in 10 weeks with nearly 12,000 views on the campaign page and nearly 2,000 sign-ups to the campaign email.
Our Facebook page reaches 489,000 people and our organic post reach is over 72,500.
Our monthly newsletter has an open rate of over 56%.
Download the Anaphylaxis UK Business Member logos along with the Brand Guidelines. Please use the Brand Guidelines on how to correctly display the logos and link to the Anaphylaxis Homepage: https://www.anaphylaxis.org.uk/
The Anaphylaxis UK Business Member logos

The Anaphylaxis UK Brand Guidelines

Access training for you and colleagues here. The training courses are only available to Business Members.
Get the latest news. To feature news of your own, get in touch!
The Anaphylaxis Campaign is delighted to hear about the success of Aimmune Therapeutics, Inc. Phase 3 PALISADE trial and publication of its results in the New England Journal of Medicine. PALISADE (Peanut Allergy oral Immunotherapy Study of AR101 for Desensitization, is an international, randomized (3:1),
Today Mohammed Abdul Kuddus was jailed for two years and Harun Rashid for three years after being found guilty of manslaughter last month. After eating takeaway food containing peanuts from the Royal Spice Indian in Hyndburn, Lancashire on Friday December
Welcome to Leo’s Story Chapter 3 which brings the latest results from the pan-European APPEAL (Allergy to Peanuts impacting Emotions And Life) Study to life. The Anaphylaxis Campaign is a member of Team APPEAL which is a large two-phase study
Some of our Business Members are featured here.

Update your subscription details
Go nowUpdate your company details and logo
Go nowPlease complete the details below so we can set up your new account.